Abbott Laboratories, Inc.

Abbott Laboratories is a multinational healthcare company that discovers, develops, manufactures, and commercializes medical devices, pharmaceuticals, diagnostics, and nutritional products for use across the spectrum of health care. The company's business segments include medical devices including cardiovascular devices, rhythm management devices, structural heart devices, neuromodulation systems, vascular products, and point-of-care diagnostic equipment; diagnostics and informatics including clinical laboratory diagnostics, molecular diagnostics, immunoassays, point-of-care testing, and digital health informatics platforms including the Alinity family of laboratory systems; nutrition including infant formula, pediatric nutritional products, and adult nutritional supplements for specific health conditions and wellness; and branded generic pharmaceutical products marketed internationally. Abbott's product portfolio includes pacemakers, implantable cardioverter defibrillators, neuromodulation devices, structural heart repair devices, coronary and vascular stents, catheters, glucose monitoring systems, diagnostic assays and testing kits, infant formula under brand names including Similac, adult nutritional liquids, and branded generic medicines. The company operates in over one hundred sixty countries and has a global sales footprint with approximately sixty percent of revenues derived from international markets. Abbott was founded in 1888 by Wallace Calvin Abbott as Abbott Alkaloidal Company in Ravenswood, Chicago, and is headquartered in Abbott Park, Illinois, United States.